IE
EDSA icon

Israel Englander’s Edesa Biotech EDSA Stock Holding History

Israel Englander’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57M Buy
+561,751
New +$5.07M ﹤0.01% 3073
2022
Q4 		– Sell
-2,555
Closed -$16K – 6666
2022
Q3 		$16K Sell
2,555
-5,125
-67% -$63.1K ﹤0.01% 6518
2022
Q2 		$86K Buy
+7,680
New +$113K ﹤0.01% 5995
2018
Q4 		– Sell
-403
Closed -$24K – 3833
2018
Q3 		$24K Buy
+403
New +$25.7K ﹤0.01% 3826

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's EDSA Position: Q2 2026 in Review

Israel Englander opened a new position in Edesa Biotech (EDSA) in Q2 2026: 561,751 shares worth $4.57M. The stake represents ﹤0.01% of the portfolio and ranks #3073 among its holdings. This is a return to the name: Israel Englander previously reported a position in EDSA as recently as Q3 2022.

Israel Englander first reported a position in EDSA in Q3 2018 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Israel Englander held 561,751 shares of Edesa Biotech worth $4.57M as of Q2 2026.
  • Edesa Biotech was a new Israel Englander position in Q2 2026.
  • Edesa Biotech made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3073 holding.
  • Israel Englander first reported a position in Edesa Biotech in Q3 2018 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.